Company intelligence / Profile preview

Auggi

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Auggi developed AI algorithms for real-time Bristol stool typing with 94.07% accuracy, a large stool image database, and a mobile app for symptom tracking; technology acquired by Seed Health in 2021 for integration into clinical trials and consumer products.

Therapeutic areas: Gastroenterology
Industry: Digital Health Medical Devices

Partnerships

Seed HealthMassachusetts General HospitalBeth Israel Deaconess Medical CenterCornell Tech

Beyond the preview

Go deeper on Auggi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Auggi.

Explore the full profile